These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Regulation of water-electrolyte balance in cirrhosis of the liver]. Winnicki C Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):361-4. PubMed ID: 2146600 [No Abstract] [Full Text] [Related]
3. [Pathogenesis of sodium and water retention in cirrhosis of the liver]. Martin PY Praxis (Bern 1994); 1997 Jul; 86(31-32):1194-7. PubMed ID: 9340706 [TBL] [Abstract][Full Text] [Related]
4. [Homeostatic mechanisms in decompensated cirrhosis. Ascites--status and perspectives]. Henriksen JH Nord Med; 1984; 99(6-7):177-80. PubMed ID: 6473089 [No Abstract] [Full Text] [Related]
5. The 'overflow' theory of ascites formation: a fading concept? Henriksen JH Scand J Gastroenterol; 1983 Oct; 18(7):833-7. PubMed ID: 6374865 [No Abstract] [Full Text] [Related]
7. [Electrolyte metabolism anomalies in liver cirrhosis]. Okumura M; Katsuki S Saishin Igaku; 1968 Dec; 23(12):2527-33. PubMed ID: 4889816 [No Abstract] [Full Text] [Related]
8. [Differential diagnosis and pathophysiologic principles of ascites]. Paumgartner G; Gerbes AL Chirurg; 1993 Jan; 64(1):1-6. PubMed ID: 8382146 [No Abstract] [Full Text] [Related]
9. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function. Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355 [TBL] [Abstract][Full Text] [Related]
10. Fluid and electrolyte management of ascites in patients with cirrhosis. Bass M Crit Care Nurs Clin North Am; 1998 Dec; 10(4):459-67. PubMed ID: 10326425 [TBL] [Abstract][Full Text] [Related]
11. Fluid retention in cirrhosis: pathophysiology and management. Kashani A; Landaverde C; Medici V; Rossaro L QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668 [TBL] [Abstract][Full Text] [Related]
12. [The pathophysiology of ascites formation in cirrhosis of the liver]. Benjaminov FS Harefuah; 2002 Aug; 141(8):721-5, 760. PubMed ID: 12222138 [TBL] [Abstract][Full Text] [Related]
13. [In-vitro exchange of 42 K between plasma and erythrocytes in the course of ascitic liver cirrhosis]. Afifi F; Boivin P; Fauvert R Pathol Biol (Paris); 1972 Feb; 20(3):159-64. PubMed ID: 4553276 [No Abstract] [Full Text] [Related]
14. Physiologic considerations in the medical management of ascites. Frakes JT Arch Intern Med; 1980 May; 140(5):620-3. PubMed ID: 7396587 [TBL] [Abstract][Full Text] [Related]
15. [Water and salt metabolism in the hepatopathic patient, with special reference to hypokalemia]. Santagostino A G Gerontol; 1972 Jun; 20(6):535-41. PubMed ID: 5046893 [No Abstract] [Full Text] [Related]
16. [Present views on the physiopathology of water and electrolyte metabolism and acid-base equilibrium in hepatic cirrhosis]. Maschio G Recenti Prog Med; 1969 Nov; 47(5):411-9. PubMed ID: 4908463 [No Abstract] [Full Text] [Related]
17. [Physiopathology and therapy of the ascites in liver cirrhosis]. Bernardi M; Trevisani F; Santini C; Pini P; Turci P G Clin Med; 1982 Oct; 63(10):744-52. PubMed ID: 7182199 [No Abstract] [Full Text] [Related]
18. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites]. Peña JC Rev Invest Clin; 1995; 47(1):63-79. PubMed ID: 7777718 [TBL] [Abstract][Full Text] [Related]
19. [Natural course and physiopathology of ascites in the cirrhotic patient]. Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites. Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]